Alcyone Lifesciences nabs $4 mln
Alcyone Lifesciences has raised $4 million in Series B financing. Edgar D. Jannotta, Jr. led the round with participation from Harbor Light Capital Partners. Based in Concord, Mass., Alcyone Lifesciences develops products that treat neuropathological conditions.
16 January 2014•2 mins read
